Kolon Life Science Inc. (KOSDAQ:102940)
South Korea · Delayed Price · Currency is KRW 49,600
+400 (0.81%)
Jun 12, 2026, 3:30 PM KST
Kolon Life Science Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 35,327 | 24,960 | -93,086 | -30,726 | 2,133 | -1,375 |
Depreciation & Amortization | 10,040 | 9,763 | 8,876 | 8,831 | 9,467 | 11,299 |
Loss (Gain) From Sale of Assets | 32.8 | 26.52 | 1,013 | -3,477 | 760.83 | -72.29 |
Asset Writedown & Restructuring Costs | 1,675 | 1,434 | 8,855 | 4,350 | 2,822 | 4,327 |
Loss (Gain) From Sale of Investments | - | - | - | 14.53 | 5.18 | -11.07 |
Provision & Write-off of Bad Debts | - | - | -78.01 | 78.01 | - | -375.82 |
Other Operating Activities | -8,698 | 4,596 | 59,296 | 6,571 | -3,413 | 2,146 |
Change in Accounts Receivable | 680.37 | -655.98 | -11,060 | 4,713 | -10,666 | 2,502 |
Change in Inventory | -14,096 | -10,272 | 3,176 | -2,126 | -23,842 | -3,810 |
Change in Accounts Payable | 43.73 | 755.51 | 3,758 | -5,448 | 3,420 | 1,952 |
Change in Unearned Revenue | - | - | - | - | -299 | - |
Change in Other Net Operating Assets | -22,227 | -20,398 | 5,165 | -7,645 | -3,125 | -32,771 |
Operating Cash Flow | 2,778 | 10,209 | -14,085 | -24,866 | -20,854 | -16,187 |
Capital Expenditures | -27,312 | -38,264 | -8,194 | -10,144 | -6,305 | -4,413 |
Sale of Property, Plant & Equipment | 108.84 | 109 | 90 | - | 20.14 | 168 |
Sale (Purchase) of Intangibles | -221.95 | -123.78 | -532.44 | 3,407 | -2.2 | -43 |
Investment in Securities | - | - | - | -14.53 | 360 | 2,224 |
Other Investing Activities | 9,034 | 13,557 | 2,255 | -274.48 | -9.13 | -190.45 |
Investing Cash Flow | -18,391 | -24,722 | -6,382 | -7,026 | -5,937 | -2,255 |
Short-Term Debt Issued | - | 116,982 | 96,136 | 128,212 | 101,092 | 121,103 |
Long-Term Debt Issued | - | 10,000 | 12,000 | 9,975 | - | - |
Total Debt Issued | 129,001 | 126,982 | 108,136 | 138,187 | 101,092 | 121,103 |
Short-Term Debt Repaid | - | -143,451 | -87,961 | -100,437 | -90,238 | -123,741 |
Long-Term Debt Repaid | - | -949.14 | -845.6 | -4,861 | -6,049 | -5,978 |
Total Debt Repaid | -141,300 | -144,400 | -88,806 | -105,298 | -96,287 | -129,718 |
Net Debt Issued (Repaid) | -12,299 | -17,418 | 19,330 | 32,889 | 4,804 | -8,615 |
Issuance of Common Stock | - | - | 20,000 | - | - | - |
Other Financing Activities | 29,956 | 29,963 | -14,551 | -0 | 653.6 | 39,564 |
Financing Cash Flow | 17,657 | 12,545 | 24,779 | 32,889 | 5,458 | 30,949 |
Foreign Exchange Rate Adjustments | 150.43 | 104.61 | 625.08 | 192.24 | -96.34 | 292.46 |
Net Cash Flow | 2,195 | -1,862 | 4,937 | 1,190 | -21,429 | 12,799 |
Free Cash Flow | -24,533 | -28,055 | -22,279 | -35,009 | -27,159 | -20,600 |
Free Cash Flow Margin | -11.47% | -13.43% | -13.80% | -28.09% | -16.81% | -12.45% |
Free Cash Flow Per Share | -1678.84 | -1957.83 | -1865.41 | -3067.66 | -2149.14 | -1807.01 |
Cash Interest Paid | 5,978 | 6,634 | 7,443 | 5,116 | 2,992 | 2,459 |
Cash Income Tax Paid | 729.05 | 268.24 | -6.78 | 112.55 | 0.82 | -32.94 |
Levered Free Cash Flow | -50,613 | -48,026 | 48,671 | -15,476 | -26,124 | -25,821 |
Unlevered Free Cash Flow | -46,188 | -43,161 | 53,303 | -11,815 | -23,798 | -22,063 |
Change in Working Capital | -35,599 | -30,571 | 1,039 | -10,507 | -34,513 | -32,126 |